Prevention of ischemia-reperfusion damage with polymerized superoxide dismutase

Boll Soc Ital Biol Sper. 1995 May-Jun;71(5-6):125-32.

Abstract

The efficacy of preventing ischemia-reperfusion damage by employing native or modified (mPEG-SOD) superoxide dismutase in an experimental model of acute ischemia was tested in the left hind limb of 43 Wistar rats. A significative difference (p=0.004) of the survival leg rate was found in the group treated with mPEG-SOD (86.6%) compared with the control group (30%). This difference was confirmed both clinically and by TEM analysis of muscular specimens.

MeSH terms

  • Animals
  • Combined Modality Therapy
  • Femoral Artery / surgery
  • Hindlimb / blood supply
  • Ischemia / drug therapy*
  • Ischemia / surgery
  • Male
  • Microscopy, Electron
  • Microsurgery
  • Polyethylene Glycols / administration & dosage
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / prevention & control*
  • Superoxide Dismutase / administration & dosage
  • Superoxide Dismutase / pharmacokinetics
  • Superoxide Dismutase / therapeutic use*

Substances

  • Reactive Oxygen Species
  • Polyethylene Glycols
  • monomethoxypolyethylene glycol
  • Superoxide Dismutase